Gutfreund John Peter - Insider Non-Derivative Transactions at Oncocyte Corp (OCX) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jun 30, 2023, Gutfreund John Peter's relationship to Oncocyte Corp (OCX) is Other, and currently has 0 shares of Common Stock, no par value.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other OCX insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Gutfreund John Peter - Insider Non-Derivative Transactions of OCX Common Stock, no par value

Gutfreund John Peter - Insider Non-Derivative Transactions at OCX

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jul 1, 2023	J -- (Common Stock, no par value)	3085047	0	0
Apr 4, 2023	Acquisition -- (Common Stock, no par value)	705000	0.35	715000
Apr 4, 2023	Acquisition -- (Common Stock, no par value)	1000000	0.35	1075000